We are live on ! Find out more
SBCWW

SBC Medical Group Warrants
SBCWW

28 hedge funds and large institutions have $17.9M invested in SBC Medical Group Warrants in 2022 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

261% more capital invested

Capital invested by funds: $4.95M → $17.9M (+$12.9M)

155% more funds holding

Funds holding: 11 → 28 (+17)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Holders
28
Holders Change
+17
Holders Change %
+154.55%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
2
Reduced
2
Closed
–
Calls
$1.53M
Puts
–
Net Calls
+$1.53M
Net Calls Change
+$36K

Top Buyers

Rank Fund Capital Flow
1
MP
Mangrove Partners
Connecticut
+$44.1K
2
CCM
Context Capital Management
California
+$19.7K
3
SIA
Schechter Investment Advisors
Michigan
+$18.4K
4
AA
AQR Arbitrage
Connecticut
+$17.4K
5
TCA
Taconic Capital Advisors
New York
+$16.8K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$1.95K
2
CAC
Cowen and Company
New York
-$469
Name Holding Trade Value Shares
Change 		Change in
Stake
MP
1
Mangrove Partners
Connecticut
$9.69M +$44.1K +950,000 New
BFM
2
Boothbay Fund Management
New York
$4.77M +$431 +9,289 +2%
RCM
3
Radcliffe Capital Management
Pennsylvania
$3.06M +$13.9K +300,000 New
PAMP
4
Polar Asset Management Partners
Ontario, Canada
$57.1K – – –
SCM
5
Shaolin Capital Management
Florida
$30K – – –
ASM
6
ATW SPAC Management
New York
$27.3K – – –
Hudson Bay Capital Management
7
Hudson Bay Capital Management
Connecticut
$23.1K – – –
CCM
8
Context Capital Management
California
$23K +$19.7K +425,000 New
SIA
9
Schechter Investment Advisors
Michigan
$21.8K +$18.4K +395,610 New
AA
10
AQR Arbitrage
Connecticut
$20.7K +$17.4K +375,000 New
TCA
11
Taconic Capital Advisors
New York
$20K +$16.8K +363,000 New
MI
12
MMCAP International
Cayman Islands
$18.2K +$15.3K +330,000 New
PC
13
Periscope Capital
Ontario, Canada
$16.5K +$13.9K +299,800 New
WAM
14
Weiss Asset Management
Massachusetts
$16.5K – – –
WAM
15
Wolverine Asset Management
Illinois
$14.3K – – –
SCM
16
Saba Capital Management
New York
$11K +$1.97K +42,457 +27%
AC
17
Aristeia Capital
Connecticut
$9.93K – – –
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$9.51K +$8K +172,500 New
SFM
19
Spartan Fund Management
Canada
$7K +$6.19K +133,444 New
CAC
20
Cowen and Company
New York
$6.97K -$469 -10,100 -7%
WC
21
Wealthspring Capital
New York
$2.57K +$2.17K +46,700 New
CS
22
Clear Street
New York
$2K +$2.02K +43,490 New
MC
23
Meteora Capital
Florida
$1.98K +$1.67K +35,900 New
Parallax Volatility Advisers
24
Parallax Volatility Advisers
California
$1.93K +$1.62K +35,000 New
WA
25
Whitebox Advisors
Minnesota
$1.93K +$1.62K +35,000 New
1
2

SBCWW Hedge Fund Activity: Q4 2022 in Review

28 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in SBC Medical Group Warrants (SBCWW) for Q4 2022, worth a combined $17.9M — up 261% from $4.95M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new SBCWW positions and 0 closed out — a net gain of 17 holders — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Mangrove Partners, opening a new position worth an estimated $44.1K. The largest seller was Citadel Advisors, cutting an estimated $1.95K.

  • 28 institutional investors held SBC Medical Group Warrants (SBCWW) as of Q4 2022, up from 11 in Q3 2022.
  • Funds reported $17.9M of SBC Medical Group Warrants stock for Q4 2022, up 261% quarter-over-quarter.
  • 17 funds opened new SBC Medical Group Warrants positions in Q4 2022 and 0 closed out, a net change of +17 holders.
  • The largest SBC Medical Group Warrants buyer in Q4 2022 was Mangrove Partners, an estimated $44.1K added.
  • The largest SBC Medical Group Warrants seller in Q4 2022 was Citadel Advisors, an estimated $1.95K sold.

Based on aggregated 13F filings for Q4 2022.